CIMAC Data and Results Sample Clauses

CIMAC Data and Results. (a) The CIMAC Data will be accessible through the CIDC and available for use by the Provider and the CIMACs that generated the data from the Human Material for the performance of the Research Project or by a CIMAC/CIDC approved by NCI to perform Cross-Trial Analysis. (b) Each Recipient CIMAC will transfer the CIMAC Data it generates from the Human Material as well as all Results to CIDC promptly after such CIMAC Data or Results are available. (c) CIDC will be responsible for notifying Provider of the availability of the CIMAC Data and Results from the Recipient CIMACs in the CIDC. (d) After all RCDE have been provided to CIDC, Provider will, through the CIDC, have access to the available CIMAC Data generated by the Recipient CIMAC(s) from the Human Material, and to the Results generated. (e) The Recipient CIMACs will have full access to and use of the CIMAC Data and Results, in accordance with this Agreement. Provider will have use of the Results and the CIMAC Data generated from the Human Material without accounting to the other Party(ies) after the expiration of the Exclusivity Period and in compliance with the Sections on Publication and Authorship of this Agreement. Recipients will at all times retain rights to use Results and the CIMAC Data for all purposes in accordance with this Agreement. (f) The Recipient CIMAC will solely own all CIMAC Data that it generates that is not specifically related to a Research Project (for example, improvements to assays that are not directly related to specific Human Material). Each Recipient CIMAC will have full rights to use the CIMAC Data that it generates that is not specifically related to the Research Project or use of the Human Material (for example, improvements to assays that are not directly related to specific Human Material). (g) CIDC will transfer Clinical Data, Results, and CIMAC Data to NCI promptly after each data set is complete, but no later than at the time of publication, or, if no publication, then twelve (12) months from the completion of the relevant data set. (h) The Parties understand that, after the Exclusivity Period and consistent with all NCI and NIH data sharing and public access policies, the CIMAC Data, Clinical Data, and Results provided to the NCI from the CIDC will be made available in controlled-access data archives or data commons for sharing with approved requestors from the general research community.
Sample 1Sample 2
AutoNDA by SimpleDocs
CIMAC Data and Results. (a) Each Recipient CIMAC will transfer the CIMAC Data they generate from the Human Material as well as all Results to CIDC as soon as the data are available. (b) CIDC will be responsible for notifying Provider of the availability of the CIMAC Data and Results in the CIDC. (c) After all RCDE have been provided to CIDC, Provider will have access to and use of the CIMAC Data as well as the Results generated from the Human Material through the CIDC. Provider and Recipient will jointly own all rights, title, and interest in and to all such CIMAC Data and Results. Each Party may use such CIMAC Data and Results without accounting to the other Party. (d) Each Recipient will own the data they generate that is not related to the Research Project.
Sample 1
CIMAC Data and Results. Each Recipient CIMAC will transfer the CIMAC Data they generate from the Human Material as well as all Results to CIDC as soon as the data are available. CIDC will be responsible for notifying Provider of the availability of the CIMAC Data and Results in the CIDC. After all RCDE have been provided to CIDC, Provider will have access to and use of the CIMAC Data as well as the Results generated from the Human Material through the CIDC. Provider and Recipient will jointly own all rights, title, and interest in and to all such CIMAC Data and Results. Each Recipient will own the data they generate that is not related to the Research Project.
Sample 1

Related to CIMAC Data and Results

  • BID TABULATION AND RESULTS Bid tabulations shall be available thirty (30) days after opening on the Orange County website at: xxxx://xxxx.xxxx.xxx/orangebids/bidresults/results.asp or upon notice of intended action, whichever is sooner.

  • Books, Records and Regulatory Filings (a) The Sub-Adviser agrees to maintain and to preserve for the applicable periods any such records as are required to be maintained by the Sub-Adviser with respect to the Fund by the 1940 Act and rules adopted thereunder, and by any other applicable laws, rules and regulations. The Sub-Adviser further agrees that all records that it maintains for the Fund are the property of the Fund and it will promptly surrender any of such records upon request; provided, however, that the Sub-Adviser may retain copies of such records for the applicable periods they are required by law to be retained, and thereafter shall destroy such records. (b) The Sub-Adviser agrees that it shall furnish to regulatory authorities having the requisite authority any information or reports in connection with its services hereunder that may be requested in order to determine whether the operations of the Fund are being conducted in accordance with applicable laws, rules and regulations. (c) The Sub-Adviser shall make all filings with the SEC required of it pursuant to Section 13 of the 1934 Act with respect to its duties as are set forth herein. The Sub-Adviser also shall make all required filings on Schedule 13D or 13G and Form 13F (as well as other filings triggered by ownership in securities under other applicable laws, rules and regulations) in respect of the Portfolio as may be required of the Fund due to the activities of the Sub-Adviser. The Sub-Adviser shall be the sole filer of Form 13F with respect to the Portfolio of the Fund.

  • Licensed Documentation If commercially available, Licensee shall have the option to require the Contractor to deliver, at Contractor’s expense: (i) one (1) hard copy and one (1) master electronic copy of the Documentation in a mutually agreeable format; (ii) based on hard copy instructions for access by downloading from the Internet

  • Data To permit evaluation of requests under paragraph (c) of this clause based on unreasonable cost, the Contractor shall include the following information and any applicable supporting data based on the survey of suppliers: Foreign (Nondesignated Country) and Domestic Construction Materials Cost Comparison Construction material description Unit of measure Quantity Cost (dollars) * Item 1: Foreign construction material Domestic construction material Item 2 Foreign construction material Domestic construction material [List name, address, telephone number, and contact for suppliers surveyed. Attach copy of response; if oral, attach summary.][Include other applicable supporting information.] [* Include all delivery costs to the construction site.]

  • MATERIAL SAFETY DATA SHEETS As applicable, Contractor shall provide Purchaser with all appropriate Material Safety Data Sheets (“MSDS”) at the time of delivery of each shipment of Goods which requires such compliance and/or and for materials used by Contractor while performing Services and any updates of the same.

  • Statistical Sampling Documentation a. A copy of the printout of the random numbers generated by the “Random Numbers” function of the statistical sampling software used by the IRO.‌ b. A description or identification of the statistical sampling software package used by the IRO.‌

  • SERVICE MONITORING, ANALYSES AND ORACLE SOFTWARE 11.1 We continuously monitor the Services to facilitate Oracle’s operation of the Services; to help resolve Your service requests; to detect and address threats to the functionality, security, integrity, and availability of the Services as well as any content, data, or applications in the Services; and to detect and address illegal acts or violations of the Acceptable Use Policy. Oracle monitoring tools do not collect or store any of Your Content residing in the Services, except as needed for such purposes. Oracle does not monitor, and does not address issues with, non-Oracle software provided by You or any of Your Users that is stored in, or run on or through, the Services. Information collected by Oracle monitoring tools (excluding Your Content) may also be used to assist in managing Oracle’s product and service portfolio, to help Oracle address deficiencies in its product and service offerings, and for license management purposes. 11.2 We may (i) compile statistical and other information related to the performance, operation and use of the Services, and (ii) use data from the Services in aggregated form for security and operations management, to create statistical analyses, and for research and development purposes (clauses i and ii are collectively referred to as “Service Analyses”). We may make Service Analyses publicly available; however, Service Analyses will not incorporate Your Content, Personal Data or Confidential Information in a form that could serve to identify You or any individual. We retain all intellectual property rights in Service Analyses. 11.3 We may provide You with the ability to obtain certain Oracle Software (as defined below) for use with the Services. If we provide Oracle Software to You and do not specify separate terms for such software, then such Oracle Software is provided as part of the Services and You have the non-exclusive, worldwide, limited right to use such Oracle Software, subject to the terms of this Agreement and Your order (except for separately licensed elements of the Oracle Software, which separately licensed elements are governed by the applicable separate terms), solely to facilitate Your use of the Services. You may allow Your Users to use the Oracle Software for this purpose, and You are responsible for their compliance with the license terms. Your right to use any Oracle Software will terminate upon the earlier of our notice (by web posting or otherwise) or the end of the Services associated with the Oracle Software. Notwithstanding the foregoing, if Oracle Software is licensed to You under separate terms, then Your use of such software is governed by the separate terms. Your right to use any part of the Oracle Software that is licensed under the separate terms is not restricted in any way by this Agreement.

  • Complete and Accurate Information Contractor represents and warrants that all statements and information provided to HHS are current, complete, and accurate. This includes all statements and information in this Contract and any related Solicitation Response.

  • Billing Information 6.1 NLT and the RL shall provide each other with information within their possession that is necessary to allow them to provide accurate and timely billing to each other and to any other relevant third parties.

  • Operator Materials Operator retains all right, title and interest in and to any and all of Operator’s software, materials, tools, forms, documentation, training and implementation materials and intellectual property (“Operator Materials”). Operator grants to the LEA a personal, nonexclusive license to use the Operator Materials for its own non-commercial, incidental use as set forth in the Service Agreement. Operator represents that it has all intellectual property rights necessary to enter into and perform its obligations in this DPA and the Service Agreement, warrants to the District that the District will have use of any intellectual property contemplated by the Service Agreement free and clear of claims of any nature by any third Party including, without limitation, copyright or patent infringement claims, and agrees to indemnify the District for any related claims.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!